Technology
Aug. 8, 2012 โ The U.S. Food and Drug Administration (FDA) approved the Abbottโs Omnilink Elite Vascular Balloon-Expandable Stent System for the treatment of iliac artery disease. This form of peripheral artery disease (PAD) that affects the lower extremities can progress to where patients experience chronic pain and reduced ability to walk, potentially leading to permanent disability.
August 08, 2012
Technology
Aug. 8, 2012 โ Vascular Solutions Inc. launched the SuperCross FT, a new flexible-tip version of its line of SuperCross microcatheters. It is designed to address the majority of complex interventional procedures in which a flexible tipped microcatheter is needed.
August 08, 2012
News
FDA Clears Post Approval Study Protocol for Berlin Heart's Excor Pediatric Ventricular Assist Device
Aug. 8, 2012 โ The Berlin Heart Group said the U.S. Food and Drug Administration (FDA) has granted approval for its post approval study, a condition of the humanitarian device exemption (HDE) approval that Berlin Heart received for the Excor Pediatric Ventricular Assist Device (VAD) in December 2011.
August 08, 2012Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
Aug. 8, 2012 โ iHeart Centers acquired the Heart IT WebPAX system for facilitating the management of medical images. The zero-footprint medical image workstation provides Web-based medical image management technology and services to healthcare systems, large hospitals and private clinics.
August 08, 2012
News
August 3, 2012 โ In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable surgical site infections following cardiac implantable electronic device (CIED) procedures. These include pacemaker and defibrillator implants.
August 03, 2012
News
August 3, 2012 โ St. Jude Medical recently announced initial findings from the Riata lead evaluation study. The studyโs phase I results found that externalized conductors occurred in 9.3 percent of the smaller-diameter Riata ST 7 French leads in the study, and in 24 percent of the larger-diameter Riata 8 French leads.
August 03, 2012Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
August 3, 2012 โ GE Healthcare announced it has already received six orders for its Discovery IGS 730 system since receiving U.S. Food and Drug Administration (FDA) clearance in February 2012.
August 03, 2012
News
August 3, 2012 โ FluoroPharma Medical Inc. announced that they have received high-quality images in an investigator-sponsored clinical trial in China where patients with coronary artery disease (CAD) were given BFPET, its imaging agent for measuring cardiovascular blood flow.
August 03, 2012
News
August 2, 2012 โ According to new research published in the August issue of the Journal of Nuclear Medicine, single photon emission computed tomography/computed tomography (SPECT/CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the diagnosis of infectious endocarditis in hard-to-diagnose cases.
August 02, 2012Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
August 2, 2012 โ Results of the ROMICAT II trial indicates coronary computed tomography (CT) angiography (CCTA) as a safe and time-efficient noninvasive modality to evaluate patients with chest pain in the emergency department (ED) when compared to the current standard approach.
August 02, 2012
News
August 2, 2012 โ The Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) has released the HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection, the first of its kind to specifically address pacemaker device and mode selection.
August 02, 2012
Feature | Suzanne Winter, general manager, GE Healthcare interventional systems, Americas
Interventional procedures are growing rapidly and becoming more specialized in diverse areas of care. In the next decade, the number of people living in the United States who have heart conditions is expected to continue to increase, as is the elderly segment of the population and the number of people with chronic disorders such as cardiovascular disease cancer, diabetes and obesity.[1] Driven by these trends and enabled by breakthrough technology allowing new, less invasive approaches to therapy, hospitals are looking at the interventional suite as a strategic area of investment.
August 02, 2012Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
July 31, 2012 โ Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food and Drug Administration (FDA) has approved the use of MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic resonance angiography (MRA) to evaluate adults with known or suspected renal or aorto-ilio-femoral occlusive vascular disease.
July 31, 2012
News
July 31, 2012 โ Boston Scientific Corp. has received CE mark approval for use of its Ingenio and Advantio pacemakers in patients in need of a magnetic resonance image (MRI).
July 31, 2012
Feature | Mike Vintges, Novation
In the coming years, the continued growth and aging of our population will both increase the demand for treatment with implantable cardiac rhythm devices and stretch our ability to pay for care. Toward solving this, we must continue to improve clinical quality not just to provide a better future for patients, but to control costs so that we are able to meet the increased demand.
July 31, 2012ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now